Folgen
Sabine Brookman-May
Sabine Brookman-May
Professor Medizin
Bestätigte E-Mail-Adresse bei art-uro.de - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Apalutamide in patients with metastatic castration-sensitive prostate cancer: final survival analysis of the randomized, double-blind, phase III TITAN study
KN Chi, S Chowdhury, A Bjartell, BH Chung, ...
Journal of Clinical Oncology 39 (20), 2294-2303, 2021
2822021
Apalutamide and overall survival in prostate cancer
MR Smith, F Saad, S Chowdhury, S Oudard, BA Hadaschik, JN Graff, ...
European urology 79 (1), 150-158, 2021
2192021
Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation …
M May, S Brookman-Amissah, J Roigas, A Hartmann, S Störkel, ...
European urology 57 (5), 850-858, 2010
2082010
Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort
A Aziz, M May, M Burger, RJ Palisaar, QD Trinh, HM Fritsche, M Rink, ...
European urology 66 (1), 156-163, 2014
2052014
Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node–negative urothelial carcinoma of …
M May, E Herrmann, C Bolenz, S Brookman-May, A Tiemann, R Moritz, ...
Annals of surgical oncology 18, 2018-2025, 2011
1352011
Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model …
S Brookman-May, M May, SF Shariat, E Xylinas, C Stief, R Zigeuner, ...
European urology 64 (3), 472-477, 2013
1202013
Pre-operative renal arterial embolisation does not provide survival benefit in patients with radical nephrectomy for renal cell carcinoma
M May, S Brookman-Amissah, S Pflanz, J Roigas, B Hoschke, F Kendel
The British journal of radiology 82 (981), 724-731, 2009
1052009
Lymph node density affects cancer-specific survival in patients with lymph node–positive urothelial bladder cancer following radical cystectomy
M May, E Herrmann, C Bolenz, A Tiemann, S Brookman-May, HM Fritsche, ...
European urology 59 (5), 712-718, 2011
972011
Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 …
W Otto, M May, HM Fritsche, D Dragun, A Aziz, M Gierth, L Trojan, ...
Gender medicine 9 (6), 481-489, 2012
962012
External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder
P Nuhn, M May, M Sun, HM Fritsche, S Brookman-May, A Buchner, ...
European urology 61 (1), 58-64, 2012
932012
Time to recurrence is a significant predictor of cancer‐specific survival after recurrence in patients with recurrent renal cell carcinoma–results from a comprehensive multi …
SD Brookman‐May, M May, SF Shariat, G Novara, R Zigeuner, L Cindolo, ...
BJU international 112 (7), 909-916, 2013
922013
Latest evidence on the impact of smoking, sports, and sexual activity as modifiable lifestyle risk factors for prostate cancer incidence, recurrence, and progression: a …
SD Brookman-May, R Campi, JDS Henriquez, T Klatte, JF Langenhuijsen, ...
European urology focus 5 (5), 756-787, 2019
872019
The phase 3 COU-AA-302 study of abiraterone acetate plus prednisone in men with chemotherapy-naïve metastatic castration-resistant prostate cancer: stratified analysis based on …
K Miller, J Carles, JE Gschwend, H Van Poppel, J Diels, ...
European urology 74 (1), 17-23, 2018
792018
Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a
M May, PJ Bastian, S Brookman-May, HM Fritsche, D Tilki, W Otto, ...
Urologic Oncology: Seminars and Original Investigations 31 (7), 1141-1147, 2013
742013
Impact of resection technique on perioperative outcomes and surgical margins after partial nephrectomy for localized renal masses: a prospective multicenter study
A Minervini, R Campi, BR Lane, O De Cobelli, F Sanguedolce, ...
The Journal of Urology 203 (3), 496-504, 2020
722020
Post-void residual urine as a predictor of urinary tract infection—is there a cutoff value in asymptomatic men?
M May, S Brookman-Amissah, B Hoschke, C Gilfrich, KP Braun, F Kendel
The Journal of urology 181 (6), 2540-2544, 2009
702009
Final survival results from SPARTAN, a phase III study of apalutamide (APA) versus placebo (PBO) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC).
EJ Small, F Saad, S Chowdhury, S Oudard, BA Hadaschik, JN Graff, ...
Journal of Clinical Oncology 38 (15_suppl), 5516-5516, 2020
692020
Apalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): a randomised …
F Saad, E Efstathiou, G Attard, TW Flaig, F Franke, OB Goodman, ...
The Lancet Oncology 22 (11), 1541-1559, 2021
642021
Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a …
I Wolff, M May, B Hoschke, R Zigeuner, L Cindolo, G Hutterer, L Schips, ...
European Journal of Surgical Oncology (EJSO) 42 (5), 744-750, 2016
562016
Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1–pT3a localized renal cell carcinoma in a comprehensive multicenter study …
SD Brookman-May, M May, I Wolff, R Zigeuner, GC Hutterer, L Cindolo, ...
European urology 67 (5), 943-951, 2015
562015
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20